Viveve expects to price public sale of 1.56 million shares at $8.00

Bookrunners Ladenburg Thalmann and Craig-Hallum Capital Group assist

By Devika Patel

Knoxville, Tenn., May 24 – Viveve Medical, Inc. will sell 1,562,500 common shares in a public offering with a 45-day greenshoe of 234,375 additional shares, according to an S-1/A filed Tuesday with the Securities and Exchange Commission. The company has registered up to $14,375,000 of stock for the deal.

The shares will be sold at an expected price of $8.00 per share.

Ladenburg Thalmann & Co. Inc. and Craig-Hallum Capital Group are the bookrunners. Maxim Group LLC is the co-manager.

Proceeds will be used for general corporate purposes.

Based in Sunnyvale, Calif., Viveve is a medical device company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.